Johns Hopkins Children's Center Researchers Report Potential New Treatment Regimens for Multidrug-Resistant TB Meningitis
August 15, 2024
August 15, 2024
BALTIMORE, Maryland, Aug. 15 (TNSres) -- Johns Hopkins Medicine issued the following news release:
In a preliminary study with a small number of humans, rabbits and mice, researchers at Johns Hopkins Children's Center say they have developed four new regimens that have the potential to treat and save the lives of people with multidrug-resistant (MDR) tuberculous (TB) meningitis.
While TB meningitis -- which affects the brain and spine -- is extremely rare in the U . . .
In a preliminary study with a small number of humans, rabbits and mice, researchers at Johns Hopkins Children's Center say they have developed four new regimens that have the potential to treat and save the lives of people with multidrug-resistant (MDR) tuberculous (TB) meningitis.
While TB meningitis -- which affects the brain and spine -- is extremely rare in the U . . .